Table 2.

NxTAG RPP clinical performance before discrepant analysis (prospective sample Set).

Target	Positive Agreement (Sensitivity)			Negative Agreement (Specificity)			# “No Call” by Comparator
	TP/TP + FN	%	95% CI	TN/TN + FP	%	95% CI
Influenza A (matrix)	259/273	94.9	91.5–97.2	1822/1859	98.0	97.3–98.6	0
Influenza A H1	21/21	100	83.9–100	2091/2111	99.1	98.5–99.4	0
Influenza A H3	203/206	98.5	95.8–99.7	1872/1917	97.7	96.9–98.3	9
Influenza B	87/91	95.6	89.1–98.8	2019/2033	99.3	98.8–99.6	8
Respiratory syncytial virus A	73/73	100	95.1–100	2037/2052	99.3	98.8–99.6	7
Respiratory syncytial virus B	131/133	98.5	94.7–99.8	1978/1990	99.4	98.9–99.7	9
Respiratory syncytial virus A & B (combined)	204/206	99.0	96.5–99.7	4015/4042	99.3	99.0–99.5	16
Coronavirus 229E	21/21	100	83.9–100	2098/2111	99.4	98.9–99.7	0
Coronavirus OC43	30/31	96.8	83.3–99.9	2092/2101	99.6	99.2–99.8	0
Coronavirus NL63	62/65	95.4	87.1–99.0	2053/2065	99.4	99.0–99.7	2
Coronavirus HKU1	13/14	92.9	66.1–99.8	2113/2118	99.8	99.4–99.9	0
All coronaviruses (combined)	126/131	96.2	91.4–98.4	8356/8395	99.5	99.4–9.7	2
Human metapneumovirus	135/144	93.8	88.5–97.1	1958/1976	99.1	98.6–99.5	12
Enterovirus/Rhinovirus	286/300	95.3	92.3–97.4	1764/1832	96.3	95.3–97.1	0
Adenovirus	20/20	100	83.2–100	2078/2112	98.4	97.8–98.9	0
Parainfluenza 1	5/5	100	47.8–100	2115/2116	99.9	99.7–100	11
Parainfluenza 2	1/2	50.0	1.3–98.7	2121/2122	99.9	99.7–100	8
Parainfluenza 3	20/21	95.2	76.2–99.9	2086/2103	99.2	98.7–99.5	8
Parainfluenza 4	3/5	60.0	14.7–94.7	2116/2127	99.5	99.1–99.7	0
Human bocavirus	27/28	96.4	81.7–99.9	2081/2104	98.9	98.4–99.3	0
Chlamydophila pneumoniae	0/1	0.0	0.0–97.5	2131/2131	100	99.8–100	0
Mycoplasma pneumoniae	7/9	77.8	40.0–97.2	2121/2123	99.9	99.7–100	0